journal article·2021-02-12Open access

Overcome the barriers of the skin: exosome therapy

Gi Hoon Yang, Yoon Bum Lee, Donggu Kang, Eunjeong Choi, Yoonju Nam, Kyoung Ho Lee, Hi-Jin You, Hyo Jin Kang, Sang Hyun An, Hojun Jeon

Biomaterials Research· Volume 25· Issue 1

Abstract

Abstract Exosomes are nano-sized cargos with a lipid bilayer structure carrying diverse biomolecules including lipids, proteins, and nucleic acids. These small vesicles are secreted by most types of cells to communicate with each other. Since exosomes circulate through bodily fluids, they can transfer information not only to local cells but also to remote cells. Therefore, exosomes are considered potential biomarkers for various treatments. Recently, studies have shown the efficacy of exosomes in skin defects such as aging, atopic dermatitis, and wounds. Also, exosomes are being studied to be used as ingredients in commercialized skin treatment products. In this review, we discussed the need for exosomes in skin therapy together with the current challenges. Moreover, the functional roles of exosomes in terms of skin treatment and regeneration are overviewed. Finally, we highlighted the major limitations and the future perspective in exosome engineering.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Advancements in Transdermal Drug Delivery · Dermatology and Skin Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Research Institute of Additive Manufacturing and Regenerative Medicine, Baobab Healthcare Inc., 55 Hanyangdaehak-Ro, Ansan-si 15588, Gyeonggi-Do, South Korea.

Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), 80 Cheombok-ro, Dong-gu, Daegu 41061, South Korea.

Department of Plastic Surgery, Korea University Ansan Hospital, 123 Jeokgeum-ro, Danwon-gu, Ansan-si 15355, Gyeonggi-Do, South Korea.

Biomedical Research Center, Korea University Ansan Hospital, 123 Jeokgeum-ro, Danwon-gu, Ansan-si 15355, Gyeonggi-Do, South Korea.

References (100+)

Show source-provided references
1. 10.1038/aps.2013.5010.1038/aps.2013.50 ↗
2. 10.1007/978-1-62703-330-5_2110.1007/978-1-62703-330-5_21 ↗
3. Pelekanos RA, Sardesai VS, Futrega K, Lott WB, Kuhn M, Doran MR. Isolation and expansion of mesenchymal stem/stromal cells derived from human placenta tissue. J Vis Exp. 2016;112:e54204.
4. 10.1186/s13287-016-0465-210.1186/s13287-016-0465-2 ↗
5. 10.4252/wjsc.v6.i2.19510.4252/wjsc.v6.i2.195 ↗
6. 10.1186/s13287-015-0066-510.1186/s13287-015-0066-5 ↗
7. 10.1002/term.22010.1002/term.220 ↗
8. 10.1089/scd.2012.038510.1089/scd.2012.0385 ↗
9. 10.4252/wjsc.v6.i2.13410.4252/wjsc.v6.i2.134 ↗
10. 10.1056/NEJMp161372310.1056/NEJMp1613723 ↗
11. 10.1161/CIRCRESAHA.108.18772410.1161/CIRCRESAHA.108.187724 ↗
12. 10.1161/CIRCRESAHA.108.17682610.1161/CIRCRESAHA.108.176826 ↗
13. 10.1161/01.RES.0000151843.79801.6010.1161/01.RES.0000151843.79801.60 ↗
14. 10.1016/j.ymthe.2006.05.01610.1016/j.ymthe.2006.05.016 ↗
15. 10.1016/j.cell.2016.01.04310.1016/j.cell.2016.01.043 ↗
16. 10.1016/j.ceb.2009.03.00710.1016/j.ceb.2009.03.007 ↗
17. 10.1016/j.jprot.2010.06.00610.1016/j.jprot.2010.06.006 ↗
18. Hauser P, Wang S, Didenko VV. Apoptotic bodies: selective detection in extracellular vesicles. New York: Springer; 2017. p. 193–200.
19. 10.3402/jev.v4.2676010.3402/jev.v4.26760 ↗
20. 10.3390/biology901002110.3390/biology9010021 ↗
21. 10.1038/ki.2010.27810.1038/ki.2010.278 ↗
22. 10.1016/S0022-5320(67)80034-010.1016/S0022-5320(67)80034-0 ↗
23. 10.1083/jcb.101.3.94210.1083/jcb.101.3.942 ↗
24. 10.1038/ncb159610.1038/ncb1596 ↗
25. 10.1016/j.bbadis.2014.10.00810.1016/j.bbadis.2014.10.008 ↗
26. 10.1074/jbc.270.41.2409210.1074/jbc.270.41.24092 ↗
27. 10.1006/cimm.1997.122310.1006/cimm.1997.1223 ↗
28. 10.1126/science.287.5451.31910.1126/science.287.5451.319 ↗
29. 10.1126/science.287.5451.32110.1126/science.287.5451.321 ↗
30. 10.1073/pnas.101740010810.1073/pnas.1017400108 ↗
31. 10.1038/7350210.1038/73502 ↗
32. Mori M, Mimori K, Shiraishi T, Haraguchi M, Ueo H, Barnard GF, Akiyoshi T. Motility related protein 1 (MRP1/CD9) expression in colon cancer. Clin Cancer Res. 1998;4(6):1507–1510. 1:CAS:528:DyaK1cXktVWhsbg%3D
33. Miyake M, Nakano K, Itoi S-I, Koh T, Taki T. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res. 1996;56(6):1244–1249. 1:CAS:528:DyaK28XhsFGnsbo%3D
34. 10.1084/jem.174.6.134710.1084/jem.174.6.1347 ↗
35. 10.1084/jem.184.2.75310.1084/jem.184.2.753 ↗
36. 10.1006/cimm.1993.128510.1006/cimm.1993.1285 ↗
37. 10.1186/s13287-015-0116-z10.1186/s13287-015-0116-z ↗
38. Yeo Y, Wee R. Efficiency of exosome production correlates inversely with the developmental maturity of MSC donor. Stem Cell Res Ther. 2013;3:145.
39. 10.7150/thno.1813310.7150/thno.18133 ↗
40. 10.7150/thno.4158010.7150/thno.41580 ↗
41. 10.1021/acs.jproteome.9b0069310.1021/acs.jproteome.9b00693 ↗
42. 10.3389/fcvm.2017.0006310.3389/fcvm.2017.00063 ↗
43. 10.1186/scrt43710.1186/scrt437 ↗
44. Yan L Wu X. Exosomes produced from 3D cultures of umbilical cord mesenchymal stem cells in a hollow-fiber bioreactor show improved osteochondral regeneration activity. Cell Biol Toxicol. 2019;36(2):1–14.10.1007/s10565-019-09504-5 ↗
45. 10.1007/s13770-018-0139-510.1007/s13770-018-0139-5 ↗
46. 10.1038/s41598-018-38320-w10.1038/s41598-018-38320-w ↗
47. Taghdiri Nooshabadi V Verdi J Ebrahimi-Barough S Mowla J Atlasi MA Mazoochi T Valipour E Shafiei S Ai J Banafshe HR. Endometrial mesenchymal stem cell-derived exosome promote endothelial cell angiogenesis in a dose dependent manner: a new perspective on regenerative medicine and cell-free therapy. Arch Neurosci. 2019;6(4):e94041.10.5812/ans.94041 ↗
48. 10.1016/j.bprint.2019.e0004110.1016/j.bprint.2019.e00041 ↗
49. 10.1016/j.jhep.2015.07.03010.1016/j.jhep.2015.07.030 ↗
50. Hu L, Wang J, Zhou X, Xiong Z, Zhao J, Yu R, Huang F, Zhang H, Chen L. Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts. Sci Rep. 2016;6(1):1–11.
51. 10.1038/cddis.2016.18110.1038/cddis.2016.181 ↗
52. 10.1126/sciadv.aba168510.1126/sciadv.aba1685 ↗
53. 10.1007/s12257-020-0002-010.1007/s12257-020-0002-0 ↗
54. Montagna W. The structure and function of skin. Elsevier; 2012. p.
55. 10.1016/j.jab.2017.05.00310.1016/j.jab.2017.05.003 ↗
56. 10.1177/00221554020500020110.1177/002215540205000201 ↗
57. 10.3389/fimmu.2017.0167610.3389/fimmu.2017.01676 ↗
58. 10.1586/edm.09.7010.1586/edm.09.70 ↗
59. 10.1002/9781118140505.ch110.1002/9781118140505.ch1 ↗
60. 10.1016/j.cub.2014.09.00310.1016/j.cub.2014.09.003 ↗
61. 10.1016/j.jretconser.2018.04.00210.1016/j.jretconser.2018.04.002 ↗
62. Makrantonaki E Zouboulis C. Molecular mechanisms of skin aging: state of the art. Ann N Y Acad Sci 2007;1119(1):40–50 1 DOI: https://doi.org/10.1196/annals.1404.027.10.1196/annals.1404.027 ↗
63. 10.1046/j.1523-1747.2002.19636.x10.1046/j.1523-1747.2002.19636.x ↗
64. 10.1001/archderm.1991.0452001005200610.1001/archderm.1991.04520010052006 ↗
65. 10.1016/S0531-5565(01)00160-710.1016/S0531-5565(01)00160-7 ↗
66. 10.1007/s12079-018-0459-110.1007/s12079-018-0459-1 ↗
67. 10.1016/0190-9622(95)91342-410.1016/0190-9622(95)91342-4 ↗
68. 10.1159/00037022010.1159/000370220 ↗
69. 10.1067/mai.2000.10648410.1067/mai.2000.106484 ↗
70. 10.2332/allergolint.13-RAI-056410.2332/allergolint.13-RAI-0564 ↗
71. 10.1016/j.clindermatol.2017.03.00610.1016/j.clindermatol.2017.03.006 ↗
72. 10.1038/sj.jid.570036510.1038/sj.jid.5700365 ↗
73. 10.1016/j.jaci.2006.07.01510.1016/j.jaci.2006.07.015 ↗
74. 10.1016/j.anai.2020.08.01610.1016/j.anai.2020.08.016 ↗
75. 10.4049/jimmunol.174.6.369510.4049/jimmunol.174.6.3695 ↗
76. 10.1007/s00268-003-7397-610.1007/s00268-003-7397-6 ↗
77. 10.1097/01.prs.0000225430.42531.c210.1097/01.prs.0000225430.42531.c2 ↗
78. Pool J. Normal hemostatic mechanisms: a review. Am J Med. 1977;43(8):776–780. 1:CAS:528:DyaE2sXltlWjur0%3D
79. 10.1016/S0094-1298(20)32467-610.1016/S0094-1298(20)32467-6 ↗
80. 10.1097/MCO.0b013e3282fbd35a10.1097/MCO.0b013e3282fbd35a ↗
81. 10.1016/j.jdermsci.2010.03.00310.1016/j.jdermsci.2010.03.003 ↗
82. 10.1155/2016/272146910.1155/2016/2721469 ↗
83. 10.1159/00032264310.1159/000322643 ↗
84. de Araújo R, Lôbo M, Trindade K, Silva DF, Pereira N. Fibroblast growth factors: a controlling mechanism of skin aging. Skin Pharmacol Physiol. 2019;4(5):275–282.10.1159/000501145 ↗
85. 10.1155/2018/943918210.1155/2018/9439182 ↗
86. 10.1111/j.1524-475X.2008.00410.x10.1111/j.1524-475X.2008.00410.x ↗
87. 10.1111/j.1468-2494.2009.00490.x10.1111/j.1468-2494.2009.00490.x ↗
88. 10.1111/jocd.1219310.1111/jocd.12193 ↗
89. 10.1001/archderm.143.5.60610.1001/archderm.143.5.606 ↗
90. 10.1111/ics.1234810.1111/ics.12348 ↗
91. 10.5114/ada.2019.8744310.5114/ada.2019.87443 ↗
92. Sorg O Kuenzli S Kaya G Saurat JH. Proposed mechanisms of action for retinoid derivatives in the treatment of skin aging. J Cosmet Dermatol. 2005;4(4):237–44. https://doi.org/10.1111/j.1473-2165.2005.00198.x.10.1111/j.1473-2165.2005.00198.x ↗
93. 10.1159/00036052710.1159/000360527 ↗
94. 10.1080/14764172.2018.146123010.1080/14764172.2018.1461230 ↗
95. 10.1016/j.biopha.2018.10.07810.1016/j.biopha.2018.10.078 ↗
96. 10.1016/j.apsb.2013.12.01110.1016/j.apsb.2013.12.011 ↗
97. 10.1111/dth.1289710.1111/dth.12897 ↗
98. 10.3109/1061186090311527410.3109/10611860903115274 ↗
99. 10.1016/j.ajps.2019.11.00810.1016/j.ajps.2019.11.008 ↗
100. Mohebichamkhorami F, Alizadeh A. Skin substitutes; an updated review of products from year 1980 to 2017. J Appl Biotech Rep. 2017;4(3):615–623. 1:CAS:528:DC%2BC1MXhsVCks7nE